ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.230
+0.120 (2.92%)
Mar 9, 2026, 4:00 PM EDT - Market closed

ADC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
5241921343071,5502,485
Upgrade
Market Cap Growth
232.48%43.49%-56.31%-80.20%-37.60%-
Upgrade
Enterprise Value
7473732592641,3402,030
Upgrade
Last Close Price
4.231.991.663.8420.2032.01
Upgrade
PS Ratio
6.972.721.931.4645.71-
Upgrade
PB Ratio
--0.95-0.903.869.347.41
Upgrade
P/TBV Ratio
---3.8610.127.64
Upgrade
EV/Sales Ratio
9.935.263.731.2639.51-
Upgrade
Debt / Equity Ratio
-1.92-2.19-2.894.151.970.13
Upgrade
Net Debt / Equity Ratio
-0.93-0.95-1.010.04-0.84-1.18
Upgrade
Net Debt / EBITDA Ratio
-1.83-1.49-0.91-0.030.531.82
Upgrade
Net Debt / FCF Ratio
-1.68-1.54-1.23-0.020.592.34
Upgrade
Asset Turnover
0.240.210.170.380.06-
Upgrade
Inventory Turnover
6.946.699.1816.36--
Upgrade
Quick Ratio
4.153.374.494.886.7510.90
Upgrade
Current Ratio
4.633.824.975.317.1011.14
Upgrade
Return on Equity (ROE)
----127.99%-91.72%-110.28%
Upgrade
Return on Assets (ROA)
-23.98%-24.13%-24.54%-13.91%-28.91%-42.03%
Upgrade
Return on Capital Employed (ROCE)
-53.80%-54.10%-57.80%-30.20%-48.10%-46.30%
Upgrade
Earnings Yield
-31.86%-82.03%-179.01%-51.19%-14.84%-9.91%
Upgrade
FCF Yield
-25.24%-64.81%-90.91%-45.28%-15.27%-6.82%
Upgrade
Buyback Yield / Dilution
-26.73%-18.91%-4.55%-1.83%-17.33%-32.73%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.